Status:
UNKNOWN
COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic
Lead Sponsor:
University Hospital, Lille
Conditions:
Severe COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter observational retrospective cohort study aiming at comparing the incidence of ventilator-associated lower respiratory tract infections between COVID-19 patients from the first and the seco...
Detailed Description
CoVAPid2 is a multicenter retrospective observational cohort study aiming at comparing the incidence of ventilator-associated lower respiratory tract infections between COVID-19 patients from the firs...
Eligibility Criteria
Inclusion
- Major (18 years and older)
- Admitted to the ICU
- Intubated and mechanically ventilated for more than 48 hours
- With a confirmed community-acquired SARS-CoV2 pneumonia
Exclusion
- Refusal to participate
- Lack of social security coverage
Key Trial Info
Start Date :
November 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1136 Patients enrolled
Trial Details
Trial ID
NCT05256511
Start Date
November 15 2021
End Date
December 1 2022
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Salengro - Hopital B Chr Lille
Lille, France, 59037